Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group
Titel:
Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group
Auteur:
Aapro, M.S. van Wijk, F.H. Bolis, G. Chevallier, B. van der Burg, M.E.L. Poveda, A. de Oliveira, C.F. Tumolo, S. Scotto di Palumbo, V. Piccart, M. Franchi, M. Zanaboni, F. Lacave, A.J. Fontanelli, R. Favalli, G. Zola, P. Guastalla, J.P. Rosso, R. Marth, C. Nooij, M. Presti, M. Scarabelli, C. Splinter, T.A.W. Ploch, E. Beex, L.V.A. ten Bokkel Huinink, W. Forni, M. Melpignano, M. Blake, P. Kerbrat, P. Mendiola, C. Cervantes, A. Goupil, A. Harper, P.G. Madronal, C. Namer, M. Scarfone, G. Stoot, J.E.G.M. Teodorovic, I. Coens, C. Vergote, I. Vermorken, J.B.